28 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07437 | A4K14 - Citropin 1.1 - Sp 7 | GLFAVR8KKVASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 10.23 µM |
| dbacp07438 | A4K14 - Citropin 1.1 - Sp 7 | GLFAVR8KKVASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 16.37 µM |
| dbacp07439 | A4K14 - Citropin 1.1 - Sp 7 | GLFAVR8KKVASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 14.72 µM |
| dbacp07440 | A4K14 - Citropin 1.1 - Sp 7 | GLFAVR8KKVASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 12.1 µM |
| dbacp07441 | A4K14 - Citropin 1.1 - Sp 6 | GR8FAVIKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 35.84 µM |
| dbacp07442 | A4K14 - Citropin 1.1 - Sp 6 | GR8FAVIKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 30.19 µM |
| dbacp07443 | A4K14 - Citropin 1.1 - Sp 6 | GR8FAVIKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 34.49 µM |
| dbacp07444 | A4K14 - Citropin 1.1 - Sp 6 | GR8FAVIKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 23.78 µM |
| dbacp07445 | A4K14 - Citropin 1.1 - Sp 5 | GLFAVIKKVAS5VIKS5L | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 11.9 µM |
| dbacp07446 | A4K14 - Citropin 1.1 - Sp 5 | GLFAVIKKVAS5VIKS5L | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 9.899 µM |
| dbacp07447 | A4K14 - Citropin 1.1 - Sp 5 | GLFAVIKKVAS5VIKS5L | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 8.229 µM |
| dbacp07448 | A4K14 - Citropin 1.1 - Sp 5 | GLFAVIKKVAS5VIKS5L | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 12.42 µM |
| dbacp07449 | A4K14 - Citropin 1.1 - Sp 4 | GLFAVIKKS5ASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 8.9 µM |
| dbacp07450 | A4K14 - Citropin 1.1 - Sp 4 | GLFAVIKKS5ASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 10.51 µM |
| dbacp07451 | A4K14 - Citropin 1.1 - Sp 4 | GLFAVIKKS5ASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 7.277 µM |
| dbacp07452 | A4K14 - Citropin 1.1 - Sp 4 | GLFAVIKKS5ASVS5KGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 10.49 µM |
| dbacp07453 | A4K14 - Citropin 1.1 - Sp 3 | GLFAVS5KKVS5SVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 17.89 µM |
| dbacp07454 | A4K14 - Citropin 1.1 - Sp 3 | GLFAVS5KKVS5SVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 12.11 µM |
| dbacp07455 | A4K14 - Citropin 1.1 - Sp 3 | GLFAVS5KKVS5SVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 11.93 µM |
| dbacp07456 | A4K14 - Citropin 1.1 - Sp 3 | GLFAVS5KKVS5SVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 11.92 µM |
| dbacp07457 | A4K14 - Citropin 1.1 - Sp 2 | GLFAS5IKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 10.14 µM |
| dbacp07458 | A4K14 - Citropin 1.1 - Sp 2 | GLFAS5IKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 12.55 µM |
| dbacp07459 | A4K14 - Citropin 1.1 - Sp 2 | GLFAS5IKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 14.76 µM |
| dbacp07460 | A4K14 - Citropin 1.1 - Sp 2 | GLFAS5IKKS5ASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 12.65 µM |
| dbacp07461 | A4K14 - Citropin 1.1 - Sp 1 | GS5FAVS5KKVASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | C4-2B | Prostate Cancer | IC50 = 8.94 µM |
| dbacp07462 | A4K14 - Citropin 1.1 - Sp 1 | GS5FAVS5KKVASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | A-549 | Lung Cancer | IC50 = 12.48 µM |
| dbacp07463 | A4K14 - Citropin 1.1 - Sp 1 | GS5FAVS5KKVASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | U-87 | Brain Tumor | IC50 = 11.88 µM |
| dbacp07464 | A4K14 - Citropin 1.1 - Sp 1 | GS5FAVS5KKVASVIKGL | Synthetic | Stapled peptide enhances helical apoptosis | CCK-8 assay | MCF-7 | Breast Cancer | IC50 = 11.26 µM |